US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

25.35

+0.11030.44%

Post-market: 25.350.00000.00%16:15 EDT

Volume:499

Turnover:12.63K

Market Cap:4.06M

PE:- -

High:25.35

Open:25.33

Low:25.33

Close:25.24

52wk High:34.36

52wk Low:19.00

Shares:160.00K

Float Shares:160.00K

Volume Ratio:0.57

T/O Rate:0.31%

Dividend:1.70

Dividend Rate:6.69%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Novo Nordisk A/S Stock Falls Friday, Underperforms Market

European Equities Mixed in Friday Trading; ASML to Give Staff One-Time Bonus

MT Newswires Live

European Pharma Stocks' Underperformance Shouldn't Last

Market Chatter: Novo Nordisk's Wegovy Approved for Fatty Liver Disease Treatment by India's Drug Regulator

MT Newswires Live

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 2.11%

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

MT Newswires Live

South Korea Implements New Rules to Curb Risks from Single-Stock Leveraged ETFs

United Laboratories Unit Receives $13.5 Million Milestone Payment From Novo Nordisk

MT Newswires Live

United Laboratories Secures Novo Nordisk Milestone for Obesity Drug UBT251

Moderately bullish activity in Novo Nordisk with shares up 2.46%

Sector Update: Healthcare

MT Newswires Live

Novo Nordisk Expands Cardiometabolic Reach With New Heart Failure–Obesity Trial

Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market

Novo Nordisk announces European Commission approval of Wegovy pill

European Equities Traded in the US as American Depositary Receipts Advance Wednesday

MT Newswires Live

Novo Nordisk Takes Early Lead in Oral Weight-Loss Drug Market, Eli Lilly Aims to Catch Up

In the Weight-loss Wars, Novo's Obesity Pill is Pulling Way Ahead of Lilly's

Novo Nordisk’s New Diabetes Bet: What the UBT251 Trial Could Mean for NVO Investors

Novo Nordisk Ramps Up Share Buybacks Under DKK 15 Billion Programme

Novo Nordisk A/S Stock Rises Monday, Outperforms Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NVOH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":25.35,"timestamp":1787601600000,"preClose":25.2397,"halted":0,"volume":499,"hourTrading":{"tag":"盘后","latestPrice":25.35,"preClose":25.35,"latestTime":"16:15 EDT","volume":8,"amount":202.8,"timestamp":1787602500256,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.004370099486127105,"floatShares":160001,"shares":160001,"eps":0,"marketStatus":"Not Yet Opened","change":0.1103,"latestTime":"08-24 16:00:00 EDT","open":25.33,"high":25.35,"low":25.33,"amount":12632,"amplitude":0.000792,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":25.2397,"nav":25.208606,"aum":4033402.168606,"dividendRate":0.066907,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.35,"preClose":25.35,"latestTime":"16:15 EDT","volume":8,"amount":202.8,"timestamp":1787602500256,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.570808,"impliedVol":0.111,"impliedVolPercentile":0.11},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":160001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.570808,"shares":160001,"dividePrice":1.6961,"high":25.35,"amplitude":0.000792,"preClose":25.2397,"low":25.33,"week52Low":19,"pbRate":"--","week52High":34.36,"institutionHeld":0,"latestPrice":25.35,"eps":0,"divideRate":0.066907,"volume":499,"delay":0,"ttmEps":0,"open":25.33,"prevYearClose":27.4362,"prevWeekClose":25.2397,"prevMonthClose":25.407,"prevQuarterClose":26.0576,"fiveDayClose":24.4193,"twentyDayClose":27.1084,"sixtyDayClose":25.1269},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"NVOH","amount":0.76666,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.76666,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652828490","title":"Novo Nordisk A/S Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2652828490","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652828490?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:02","pubTimestamp":1784304120,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S slipped 1.8% to DKK329.90 Friday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.4% to 2,685.19.The stock's fall  snapped a two-day winning streak.The company closed DKK134.70 below its 52-week high of DKK464.60, which the company reached on July 28, 2025.Trading volume was 4,779,556, compared to the 50-day average trading volume of 5,289,955.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 17, 2026 12:02 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","OZEM","BK4599","LU1093756325.SGD","BK4585","BK4532","IE00BZ1G4Q59.USD","THNR","NVOH","LU0154236417.USD","NVOX","LU1093756168.USD","BK4007","IE00BKVL7J92.USD","PPH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652028455","title":"European Equities Mixed in Friday Trading; ASML to Give Staff One-Time Bonus","url":"https://stock-news.laohu8.com/highlight/detail?id=2652028455","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652028455?lang=en_us&edition=fundamental","pubTime":"2026-07-17 23:50","pubTimestamp":1784303417,"startTime":"0","endTime":"0","summary":"European stock markets closed mixed in Friday trading with the Stoxx 600 down 0.5%, Germany's DAX shedding 0.5%, the UK's FTSE 100 edging up  0.1%, France's CAC 40 declining 0.5%, and the Swiss Market","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1244550221.USD","IE00BDGV0183.EUR","NVO","EFA","SG9999015952.SGD","AGNG","LU2506952097.USD","BK4551","LU0310799852.SGD","BK4505","LU0310800379.SGD","LU0069063385.USD","LU2543165471.USD","LU0203345920.USD","LU2023251221.USD","IE000BZT7R73.USD","LU0006061336.USD","LU1585245621.USD","LU2237443465.HKD","SG9999001440.SGD","DBEF","IE00BLSP4452.SGD","JDOC","LU0859254822.USD","XLV","IYE","CGIC","LU1201861165.SGD","LU0823417737.USD","LU1037948541.HKD","LU2999663052.SGD","XPEV","LU1244550494.USD","LU0949170772.SGD","IE00BVYPNW00.USD","LU0708994859.HKD","LU2089984988.USD","IE00BKVL7J92.USD","OZEM","LU0795875169.SGD","LU0823416689.USD","LU1989772923.USD","LU2247934214.USD","LU0943347566.SGD","NERD","OILT","LU0950375773.USD","PPH","IEO","LU0882574055.USD","FTXN","IE00B19Z3581.USD","LU1551013342.USD","LU1121112475.USD","LU0368265418.SGD","LU1989772840.SGD","LU2360032135.SGD","LU1934455277.USD","LU0130103400.USD","LU0300736492.USD","FENY","IE000F7OJYX1.SGD","IE00B2Q91V27.USD","IE00BSNM7G36.USD","LU0426417589.USD","ILOW","LU0689626769.HKD","LU0792757196.USD","LU0114720955.EUR","LU1093756168.USD","RXL","COP","ABBV","LU1496350502.SGD","LU0942090050.USD","LU1983299246.USD","LU0823434740.USD","VHT","LU0965509283.SGD","GSID","LU0130102774.USD","LU0158827948.USD","BK4099","IE00BLSP4239.USD","BK4534","NVOH","LU2125154935.USD","LU0029864427.USD","LU0689472784.USD","LU1988902786.USD","03165","LU0289739343.SGD","FFGX","IE00B42XCP33.USD","IE00B7SZLL34.SGD","LU2237443382.USD","LU0097036916.USD","LU0130517989.USD","LU2506951958.HKD","NVOX","IE00BGHQF524.EUR","LU2506951875.HKD","LU1267930573.SGD","ASML","LU0170899867.USD","LU0300736062.USD","LU0203347892.USD","LU1061106388.HKD","SG9999002521.SGD","EA","IE00B3CCJ963.GBP","LU0957791311.USD","LU1732800096.USD","LU1244550577.SGD","IXC","BK4581","BK4577","IE000SO60NU8.SGD","HERO","LU0084288322.USD","IE00BFTCPJ56.SGD","ASMG","LU0154236417.USD","LU0256331488.USD","LU0985320562.USD","LU0143551892.USD","LU0795875086.SGD","LU1670627923.USD","IE0000B7K699.USD","THNR","IE00BZ1G4Q59.USD","LU0788109394.HKD","LU1023059063.AUD","LU1043141396.HKD","LU0648001328.SGD","LU0122379950.USD","LU0823434583.USD","LU2089284900.SGD","SG9999015978.USD","WEEI","LU1989771016.USD","LU0472753341.HKD","LU2063271972.USD","LU2433249047.HKD","BK4213","LU0426412945.USD","DBEU","IE00B4R5TH58.HKD","LU0630314457.HKD","LU1267930813.SGD","LU2357627491.SGD","LU1201861249.SGD","LU0553294199.USD","LU2129689514.USD","IXJ","LU2112291526.USD","LU1043141123.HKD","LU1923622614.USD","IYH","IE00BGHQF631.EUR","IE0004445239.USD","LU1815333072.USD","LU1496350171.SGD","LU0289739699.SGD","LU2264538146.SGD","BK4559","ASMU","BK4566","LU0128525929.USD","LU2237443622.USD","LU0266512127.USD","LU2237443978.SGD","LU0061474960.USD","IE00BJT1NW94.SGD","LU0868494708.USD","IEFA","LU2462591277.SGD","XPEG","LU0648000940.SGD","LU1551013425.SGD","LU0889566641.SGD","LU1162221912.USD","09868","PJP","IE0002270589.USD","BK4599","IE00B3PB1722.GBP","BK4588","LU0345774391.USD","SG9999015945.SGD","VDE","LU0198837287.USD","LU2347655156.SGD","LU2954938101.SGD","LU1732799900.SGD","BK4526","LU1934455863.HKD","BK4139","LU0345781412.USD","LU0823417653.USD","LU1093756325.SGD","LU0345780950.USD","LU2237443549.SGD","IGE","LU0417517546.SGD","LU0661504455.SGD","BK4532","LU0124676726.USD","LU0057025933.USD","LU2468319806.SGD","LU0477156953.USD","XLE","IE00BBT3K403.USD","BK4533","LU0861579265.USD","LU0965508806.USD","LU1057294990.SGD","MEDX","LU2506952170.USD","BK4550","LU0211328371.USD","BK4585","BNGE","LU1003077747.HKD","LU1037948897.HKD","LU0122376428.USD","IE000WAW04H5.SGD","LU0820561818.USD","LU1267930490.SGD","LU0912757837.SGD","LU1734074674.USD","LU1839511570.USD","LU2129689605.HKD","LU2129689431.USD","LU1291159041.SGD","LU2133065610.SGD","FHLC","LU0980610538.SGD","LU0256863811.USD","LU1929549753.HKD","BK4085","ASMH","FCG","LU0456854461.SGD","LU0320765646.SGD","LU0238689110.USD","LU0432979614.USD","IE00B19Z3B42.SGD","LU0456855351.SGD","LU0345774631.USD","LU0234570918.USD","LU1670628061.USD","LU0256863902.USD","LU0994945656.USD","BK4007","IE00B2B36J28.USD","LU0211327993.USD","LU1430594728.SGD","IE00BJJMRZ35.SGD","LU2087621335.USD","DIG","LU0314106906.USD","LU2089283258.USD","BK4555","IE0009355771.USD","LU1934455194.USD","LU1280957306.USD","LU0965509010.AUD","LU0098860793.USD","SG9999011175.SGD","ESPO","BK4147","LU0058720904.USD","BK4570","FTXH","EVS.SI","LU0820561909.HKD","IE0002141913.USD","LU1064131342.USD","LU1074936037.SGD","LU2125154778.USD","BK4543","LU0511384066.AUD","LU2125909593.SGD","LU2237443895.HKD","IE00BD6J9T35.USD","LU0289961442.SGD","LU0545039389.USD","IE00BN8TJ469.HKD","IE000MB6IJN5.SGD","LU1506573853.SGD","LU1718418525.SGD","LU2125909247.SGD","FENI","SG9999015986.USD","LU0234572021.USD","IE00BVYPNV92.GBP","SG9999003800.SGD","LU0640476718.USD","LU0965509101.SGD","LU0868494617.USD","LU0738911758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652286740","title":"European Pharma Stocks' Underperformance Shouldn't Last","url":"https://stock-news.laohu8.com/highlight/detail?id=2652286740","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652286740?lang=en_us&edition=fundamental","pubTime":"2026-07-17 22:13","pubTimestamp":1784297580,"startTime":"0","endTime":"0","summary":"1413 GMT - European pharma stocks are lagging behind the broader market, but the sector should benefit as investors start to look for trades beyond big tech, Intron Health's Naresh Chouhan and Dominic Rose say in a research note. This year's underperformance came after pricing deals with the Trump administration at the end of last year boosted the sector, Intron says. \"We do not believe investors have fallen out of love with pharma, it is just that many believe the sector is up with events for now,\" the analysts say. Upcoming strategy updates from companies like GSK, Novo Nordisk and Roche, and potential gains from AI should help pharma stocks, they add. Intron says it favors UCB, AstraZeneca, Roche and Novartis in the near term. The Stoxx Europe 600 Health Care index rises 0.3%.  Dow Jones NewswiresJuly 17, 2026 10:13 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","LU1093756168.USD","BK4588","IE00B4R5TH58.HKD","GSK.UK","LU1267930573.SGD","MEDX","LU2089984988.USD","PPH","IE00BJJMRZ35.SGD","NVO","NVOX","LU2468319806.SGD","LU0708994859.HKD","LU0128525929.USD","AZNH","BK4578","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU2237443622.USD","LU1093756325.SGD","LU0289739699.SGD","AZN","LU2462157665.USD","RHHBY","LU2237443465.HKD","LU2237443895.HKD","LU2237443978.SGD","IE00BKVL7J92.USD","IE00B2B36J28.USD","NVOH","THNR","IE00B3T34201.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","BK4568","03165","LU2236285917.USD","LU2237443549.SGD","BK4585","HRTS","LU2417539215.USD","LU0029864427.USD","BK4007","LU0208291251.USD","LU0889565916.HKD","BK4599","LU0058720904.USD","BK4532","LU0070302665.USD","CANC","EPV","GSKH","LU0154236417.USD","LU2237443382.USD","LU2456880835.USD","LU0310800379.SGD","OZEM","IE0009355771.USD","LU0211331839.USD","IE00BFTCPJ56.SGD","GSK","LU0432979614.USD","LU0109394709.USD","NVS","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652285185","title":"Market Chatter: Novo Nordisk's Wegovy Approved for Fatty Liver Disease Treatment by India's Drug Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=2652285185","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652285185?lang=en_us&edition=fundamental","pubTime":"2026-07-17 21:18","pubTimestamp":1784294292,"startTime":"0","endTime":"0","summary":"Novo Nordisk's  Wegovy received approval from India's drug regulator for use in patients with metabolic dysfunction-associated steatohepatitis, or MASH, Reuters reported Friday.MASH is a serious fatty liver disease that can cause inflammation and liver damage, according to the report.Novo Nordisk did not immediately respond to MT Newswires' request for comment.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","NVOH","NVOX","LU1093756168.USD","LU0154236417.USD","PPH","BK4007","LU1093756325.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","THNR","BK4532","NVO","OZEM","BK4585","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652294664","title":"Cboe data shows mixed options sentiment in Novo Nordisk with shares up 2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652294664","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652294664?lang=en_us&edition=fundamental","pubTime":"2026-07-17 02:05","pubTimestamp":1784225127,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares up $1.06, or 2.11%, near $51.62. Options volume running well above avera...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-up-2-11-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-up-2-11-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","NVOH","THNR","BK4007","OZEM","NVOX","BK4599","IE00BKVL7J92.USD","NVO","PPH","BK4585","LU1093756168.USD","BK4532","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651423936","title":"European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2651423936","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651423936?lang=en_us&edition=fundamental","pubTime":"2026-07-16 23:16","pubTimestamp":1784214983,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were slightly lower on Thursday morning, down 0.07% to 1,911.26 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk  and drink and brewing company Anheuser-Busch Inbev , which rose 1.9% and 0.9% respectivelyThey were followed by pharmaceutical company Novartis , which added 0.8%.The decliners from continental Europe were led by tech companies Nokia  and Ericsson , which fell 7.8% and 1.8% respectively.They were followed by bank Santander , which shed 1.5%.From the UK and Ireland, the gainers were led by advertising and PR agency WPP  and telecom giant Vodafone , which rose 3.8% and 3% respectively. They were followed by beverage company Diageo , which added 2.5%.The decliners from the UK and Ireland were led by semiconductor company Arm  and pharmaceutical company Compass Pathways , which lost 6.9% and 2.1% respectively.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4207","BUD","BK4585","LU0070302665.USD","IE00BKVL7J92.USD","IE00BMPRXR70.SGD","LU0208291251.USD","LU2543165471.USD","DEO","SAN","IE00B2B36J28.USD","QQQA","BK4141","IE00BJT1NW94.SGD","LU0154236417.USD","LU0211331839.USD","AIPI","BK4554","BK4588","DGE.UK","IE00B4R5TH58.HKD","IE00BMPRXN33.USD","NVOH","LU1093756325.SGD","BK4521","LU0006061336.USD","ARMW","IE00BJJMRZ35.SGD","NOK","BK4007","LU0320765489.SGD","BK4169","BK4609","LU0081259029.USD","BK4009","IE00BMPRXQ63.HKD","ARM","BK4578","BK4591","IE0002141913.USD","PPH","PSIL","LNOK","BK4132","BK4559","ARMG","LU1232071149.USD","MEDX","WPP","IE00BFTCPJ56.SGD","BK4547","BK4599","OZEM","IE00BZ1G4Q59.USD","BK4532","LU0348723411.USD","ARMU","NVS","BK4158","LU1093756168.USD","NVOX","BK4020","ERIC","NVO","THNR","IE0009355771.USD","BK4139","TRFK","GSIB","BK4515","SPRX","LU0266013472.USD","CMPS","BK4543","VOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181840560","title":"South Korea Implements New Rules to Curb Risks from Single-Stock Leveraged ETFs","url":"https://stock-news.laohu8.com/highlight/detail?id=1181840560","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181840560?lang=en_us&edition=fundamental","pubTime":"2026-07-16 21:12","pubTimestamp":1784207530,"startTime":"0","endTime":"0","summary":"South Korea's Financial Services Commission (FSC) has announced a set of regulatory measures aimed at managing the risks associated with single-stock leveraged exchange-traded funds (ETFs). The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SPXU","PTIR","MMAX","AAPX","PLOO","HIBL","MZZ","SOXW","SSO","SPYH","VOO","AAPW","AAPY","APLY","SPDN","PLTA","SMAX","NVOX","IVV","DMAX","AAPU","PLTD","PLTU","SPYU","SPXS","SDS","SPY","YSPY","PLTG","PLTZ","AAPD","SPXL","BK4588","SPYQ","NVOH","FNGG","PLYY","UPRO","MVPL","SPUU","SPYM","SH","PLTY","AAPB","PLTI","PLTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651413709","title":"United Laboratories Unit Receives $13.5 Million Milestone Payment From Novo Nordisk","url":"https://stock-news.laohu8.com/highlight/detail?id=2651413709","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651413709?lang=en_us&edition=fundamental","pubTime":"2026-07-16 13:04","pubTimestamp":1784178245,"startTime":"0","endTime":"0","summary":"United Laboratories International  said its subsidiary United Biotechnology received a $13.5 million milestone payment from Novo Nordisk related to the global Phase II clinical trial of UBT251 Injection for overweight or obesity treatment, according to a Thursday Hong Kong bourse filing.Shares of the pharmaceutical company were up over 2% in recent trade.The payment was received under an exclusive license agreement for UBT251. The company is eligible for up to $1.8 billion in development and sales milestone payments, along with tiered royalties tied to annual net sales.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["THNR","BK4532","IE00B3M56506.USD","NVOH","NVO","BK4588","03933","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4007","BK4599","PPH","OZEM","LU1093756325.SGD","LU0154236417.USD","NVOX","BK4585","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651841332","title":"United Laboratories Secures Novo Nordisk Milestone for Obesity Drug UBT251","url":"https://stock-news.laohu8.com/highlight/detail?id=2651841332","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651841332?lang=en_us&edition=fundamental","pubTime":"2026-07-16 12:07","pubTimestamp":1784174837,"startTime":"0","endTime":"0","summary":"The latest announcement is out from The United Laboratories International Holdings ( ($HK:3933) ). The United Laboratories International Holdings a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/united-laboratories-secures-novo-nordisk-milestone-for-obesity-drug-ubt251?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/united-laboratories-secures-novo-nordisk-milestone-for-obesity-drug-ubt251?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOX","BK4532","IE00BKVL7J92.USD","BK4007","OZEM","PPH","BK1191","NVO","BK4599","LU1093756168.USD","IE00B3M56506.USD","THNR","NVOH","LU1093756325.SGD","LU0154236417.USD","03933","IE00BZ1G4Q59.USD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651607254","title":"Moderately bullish activity in Novo Nordisk with shares up 2.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651607254","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651607254?lang=en_us&edition=fundamental","pubTime":"2026-07-16 01:45","pubTimestamp":1784137514,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Novo Nordisk (NVO), with shares up $1.21, or 2.46%, near $50.27. Options volume running well above average with 63k ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-up-2-46-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-up-2-46-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OZEM","THNR","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4532","BK4588","NVOX","LU1093756168.USD","IE00BKVL7J92.USD","BK4007","LU1093756325.SGD","BK4599","PPH","NVO","BK4585","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651467786","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2651467786","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651467786?lang=en_us&edition=fundamental","pubTime":"2026-07-16 01:11","pubTimestamp":1784135507,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index adding 0.4% and the State Street Health Care Select Sector SPDR ETF  increasing 0.3%.The iShares Biotechnology ETF  added 0.3%.In corporate news, Novo Nordisk  shares rose 2.6% after it said Wednesday the European Commission granted marketing authorization for its Wegovy pill for the treatment of adults with obesity or overweight with at least one weight-related comorbidity, as an adjunct to a reduced-calorie diet and increased physical activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","BK4599","BK4585","PPH","IE00BZ1G4Q59.USD","LABU","THNR","BK4581","OZEM","BK4007","LU1093756325.SGD","NVOH","NVOX","BK4532","XBI","LU0154236417.USD","IE00BKVL7J92.USD","BK4588","LU1093756168.USD","NVO","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651641467","title":"Novo Nordisk Expands Cardiometabolic Reach With New Heart Failure–Obesity Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2651641467","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651641467?lang=en_us&edition=fundamental","pubTime":"2026-07-16 00:31","pubTimestamp":1784133065,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk A/S is running a large Phase 3 study called “Efficacy and Saf...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-expands-cardiometabolic-reach-with-new-heart-failure-obesity-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-expands-cardiometabolic-reach-with-new-heart-failure-obesity-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOX","BK4599","LU1093756325.SGD","THNR","BK4585","LU0154236417.USD","IE00BKVL7J92.USD","NVOH","BK4532","BK4007","NVO","PPH","IE00BZ1G4Q59.USD","BK4588","OZEM","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651233462","title":"Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2651233462","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651233462?lang=en_us&edition=fundamental","pubTime":"2026-07-16 00:02","pubTimestamp":1784131320,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S advanced 3.4% to DKK330.55 Wednesday on what proved to be an overall negative trading session for the stock market, with the OMX Nordic 40 Index falling 0.1% to 2,695.76.The company closed DKK134.05 short of its 52-week high of DKK464.60, which the company achieved on July 28, 2025.Trading volume was 3,793,013, compared to the 50-day average trading volume of 5,379,766.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 15, 2026 12:02 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","NVOH","LU1093756325.SGD","NVO","LU0154236417.USD","BK4599","IE00BKVL7J92.USD","THNR","NVOX","BK4532","OZEM","BK4585","IE00BZ1G4Q59.USD","BK4007","PPH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651546247","title":"Novo Nordisk announces European Commission approval of Wegovy pill","url":"https://stock-news.laohu8.com/highlight/detail?id=2651546247","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651546247?lang=en_us&edition=fundamental","pubTime":"2026-07-16 00:00","pubTimestamp":1784131213,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) announced that the European Commission has granted marketing authorization for Wegovy pill for the treatment of adults with obes...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-european-commission-approval-of-wegovy-pill-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-european-commission-approval-of-wegovy-pill-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","BK4585","LU0154236417.USD","NVOX","OZEM","PPH","BK4532","IE00BZ1G4Q59.USD","BK4007","BK4588","THNR","LU1093756325.SGD","BK4599","NVO","NVOH","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651436464","title":"European Equities Traded in the US as American Depositary Receipts Advance Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2651436464","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651436464?lang=en_us&edition=fundamental","pubTime":"2026-07-15 23:08","pubTimestamp":1784128129,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rising on Wednesday morning, increasing 0.7% to 1,905.92 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by budget airline Ryanair  and health technology company Philips , which rose 3.9% and 3.8% respectively. They were followed by pharmaceutical giant Novo Nordisk  and healthcare firm Grifols , which added 2.9% and 2.4%.The decliners from continental Europe were led by technology company Nokia  and bank BBVA , which fell 4.7% and 1.1% respectively.From the UK and Ireland, the gainers were led by medical laboratory company Trinity Biotech  and advertising and PR agency WPP , which rose 5.9% and 3.1% respectively. They were followed by hospitality group InterContinental Hotels , which added 1.1%.The decliners from the UK and Ireland were led by telecom giant Vodafone , which shed 2.5%, and mining company Rio Tinto , which decreased 0.6%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVOX","BK4132","LU1093756325.SGD","BK4168","IE00BKVL7J92.USD","LU0154236417.USD","IE00BMPRXN33.USD","BK4007","BK4547","PPH","LU0648000940.SGD","VOD","BK4588","LU0130103400.USD","LU1093756168.USD","LU1201861165.SGD","RIO","ICOP","BK4585","BK4139","NVOH","BBVA","IE00BZ1G4Q59.USD","OZEM","TRIB","BK4548","BK4142","BK4008","IHG","BK4009","BK4020","WPP","SLX","BK4566","IE00BMPRXR70.SGD","RYAAY","BK4599","THNR","BK4207","BK4500","NOK","LU0006061336.USD","BK4532","NVO","GRFS","BK4082","LIT","PHG","LNOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191906795","title":"Novo Nordisk Takes Early Lead in Oral Weight-Loss Drug Market, Eli Lilly Aims to Catch Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1191906795","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191906795?lang=en_us&edition=fundamental","pubTime":"2026-07-15 16:23","pubTimestamp":1784103782,"startTime":"0","endTime":"0","summary":"The competition in the closely watched oral weight-loss medication market sees Eli Lilly currently trailing behind its rival Novo-Nordisk A/S. Since its launch in April, Lilly's drug Foundayo has...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","XLV","LU1280957306.USD","LU2168564495.EUR","LU2324357040.USD","LU2112291526.USD","LU2746668461.USD","LU1267930730.SGD","WDNA","LLII","LU0820562030.AUD","LU0889565916.HKD","LU0061475181.USD","LU0354030438.USD","LU2271345857.HKD","SGXZ57979304.SGD","LU0109391861.USD","IE0004445239.USD","IE00BWXC8680.SGD","SG9999014906.USD","LU1232071149.USD","LU2089283258.USD","IE00BN29S564.USD","IE00B4JS1V06.HKD","LU2237438978.USD","SGXZ81514606.USD","LU1551013342.USD","GDOC","LU0097036916.USD","IE00B1BXHZ80.USD","LU1629891620.HKD","LU2237443549.SGD","SG9999018865.SGD","LU1720051017.SGD","LU2237443465.HKD","IE00BFSS8Q28.SGD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU2237443895.HKD","LU2264538146.SGD","HRTS","LU1127390331.HKD","LU1291159041.SGD","SG9999014880.SGD","IE0005OL40V9.USD","LU0106261372.USD","LU2168564149.EUR","LU2265009873.SGD","LU0198837287.USD","LU2237443382.USD","LU2750360997.AUD","LU1868836914.USD","LU2471134796.USD","LU1069344957.HKD","LU0256863902.USD","LU1712237335.SGD","IE0001KFT4U8.USD","SG9999013999.USD","LU0203202063.USD","LLYZ","LU2471134523.USD","IE0004445015.USD","SG9999017495.SGD","RXL","LU1064131342.USD","FTXH","LU2168564222.USD","LU0672654240.SGD","LU2360106947.USD","OZEM","LU0689472784.USD","LU1974910355.USD","LU0225283273.USD","LU2417539215.USD","LU2211815571.USD","LU1988902786.USD","SG9999015986.USD","LU2023250330.USD","LU2237443622.USD","IE00BK4W5L77.USD","LU0943347566.SGD","LU0114720955.EUR","LU0823416689.USD","LU0964807845.USD","LU2602419157.SGD","LU0154236417.USD","LU0385154629.USD","LU2491049909.HKD","NVOH","BK4599","LU2462157665.USD","ELIS","LU0353189763.USD","IE00BK4W5M84.HKD","LU1868837300.USD","LU2028103732.USD","LU0316494557.USD","LU2491050071.SGD","LU2213496289.HKD","SG9999014914.USD","IE00BJJMRY28.SGD","LU0823434583.USD","LU0820561909.HKD","IE00BKDWB100.SGD","LU0203201768.USD","BK4532","LU2063271972.USD","IXJ","LU0345770308.USD","LU0882574055.USD","LU1323610961.USD","IE00BJT1NW94.SGD","CANC","LU0109394709.USD","LU1093756168.USD","LU0708995401.HKD","LU2089284900.SGD","LU0882574139.USD","LU2106854487.HKD","SG9999001176.SGD","SGXZ31699556.SGD","LU2461242641.AUD","IE00BJJMRX11.SGD","JDOC","AGNG","LU2108987350.USD","LU2756315318.SGD","LU0158827781.USD","NVO","LU0133085943.USD","BK4585","LU1366192091.USD","LU0466842654.USD","LU2552382058.USD","LU1868837136.USD","LU0323591593.USD","VHT","LU2168563687.JPY","LU1057294990.SGD","LU2023250504.SGD","IE00B7KXQ091.USD","LU2168564065.EUR","LU2361044949.HKD","LU1551013425.SGD","BK4007","IE00BKVL7J92.USD","LU1720051108.HKD","LU0266013472.USD","LU2552382215.SGD","LU0456855351.SGD","SG9999014898.SGD","IE00B1XK9C88.USD","LU1145028129.USD","LU1035775433.USD","IE00BZ1G4Q59.USD","LU0096364046.USD","LU0256863811.USD","BK4516","LU2237443978.SGD","BK4533","LU0471298777.SGD","LU0787776722.HKD","LU2491050154.USD","ILDR","LLY","LU0122379950.USD","LU0417517546.SGD","LU0238689110.USD","LU2456880835.USD","LU2552382132.HKD","LU1023059063.AUD","LU2361044865.SGD","LU0058720904.USD","IE00B775H168.HKD","LU2471134879.HKD","LU0079474960.USD","LU0158827948.USD","MEDX","LU0683600562.USD","PPH","LU2896262040.SGD","SG9999015945.SGD","LU0320765992.SGD","LU1868836757.USD","LU0345770993.USD","LU2357305700.SGD","LU2111349929.HKD","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BJLML261.HKD","LU0234572021.USD","SG9999001176.USD","SGXZ99366536.SGD","LLYX","LU0006306889.USD","LU2361045086.USD","LU0320765059.SGD","IHE","LU1093756325.SGD","LU2087625088.SGD","LU2750360641.GBP","LU0354030511.USD","NVOX","SG9999015952.SGD","LU2236285917.USD","LU0094547139.USD","LU1989771016.USD","LU0432979614.USD","LU1548497426.USD","LU1804176565.USD","LU2756315664.SGD","LU1623119135.USD","IE00BFSS7M15.SGD","LU0640476718.USD","GB00BDT5M118.USD","LU0786609619.USD","LU2023251221.USD","LU1814569148.SGD","BK4581","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BKPKM429.USD","LU1983299246.USD","SG9999015978.USD","ELIL","IE00B2B36J28.USD","SG9999018857.SGD","SGXZ51526630.SGD","LU0471298694.HKD","BK4588","LU0353189680.USD","LU1917777945.USD","LU2468319806.SGD","LU2089984988.USD","LU0820561818.USD","LU0289739699.SGD","LU1868836591.USD","LU1061106388.HKD","LU0210536198.USD","LU2471134952.CNY","LU2746668974.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651487300","title":"In the Weight-loss Wars, Novo's Obesity Pill is Pulling Way Ahead of Lilly's","url":"https://stock-news.laohu8.com/highlight/detail?id=2651487300","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651487300?lang=en_us&edition=fundamental","pubTime":"2026-07-15 08:00","pubTimestamp":1784073600,"startTime":"0","endTime":"0","summary":"The launch of weight-loss pills is the hottest battle in pharma. So far, Eli Lilly is losing to rival Novo Nordisk.Since its obesity pill Foundayo hit the market in April, Lilly has captured about 11%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2750360997.AUD","LU0109391861.USD","LU0154236417.USD","LU2237443978.SGD","ELIL","LU0672654240.SGD","LU0820561818.USD","LU2896262040.SGD","LU2361044949.HKD","IE00BFTCPJ56.SGD","SG9999015952.SGD","LU2087625088.SGD","LU1323610961.USD","SG9999017495.SGD","IHE","IE00BN29S564.USD","SG9999018857.SGD","LU0158827948.USD","LU0708995401.HKD","LU0471298777.SGD","LU1720051017.SGD","LU0320765992.SGD","LU1093756168.USD","LU1548497426.USD","IE0005OL40V9.USD","LU0786609619.USD","LU2456880835.USD","LU2471134879.HKD","LU2756315664.SGD","LU1023059063.AUD","LU1868836914.USD","LU2237443382.USD","SG9999014898.SGD","LU0823434583.USD","LU0943347566.SGD","LU1064131342.USD","LU2237443895.HKD","LU1983299246.USD","LU1988902786.USD","LU0006306889.USD","LU2552382132.HKD","PJP","LU0109394709.USD","LU0114720955.EUR","SG9999015945.SGD","LU0203201768.USD","IE00BFSS8Q28.SGD","LU0353189680.USD","LU2089283258.USD","LU1145028129.USD","SGXZ31699556.SGD","SGXZ81514606.USD","ILDR","OZEM","SGXZ51526630.SGD","IE00BJJMRZ35.SGD","IE00BJJMRX11.SGD","LU2213496289.HKD","LU1868837300.USD","LU2237443622.USD","LU0266013472.USD","LU1061106388.HKD","LLYZ","LU0203202063.USD","GDOC","IE00BK4W5L77.USD","LU0079474960.USD","LU2028103732.USD","SG9999014880.SGD","IE00BKPKM429.USD","NVO","IE00B1BXHZ80.USD","LU2417539215.USD","LU2471134523.USD","LU0354030511.USD","LU0689472784.USD","LU2237443465.HKD","LU2750360641.GBP","IE00B4JS1V06.HKD","LU2756315318.SGD","MEDX","WDNA","SG9999014914.USD","LU0058720904.USD","LU2602419157.SGD","LU1291159041.SGD","LU2168564495.EUR","LU2468319806.SGD","LU0432979614.USD","LU2063271972.USD","LU1280957306.USD","LU0820561909.HKD","CANC","IYH","IE0004445015.USD","LU2357305700.SGD","IE00BJJMRY28.SGD","LLII","LU0823434740.USD","LU2112291526.USD","BK4532","LU1267930730.SGD","IE00BWXC8680.SGD","LU0316494557.USD","SG9999015978.USD","LU0889565916.HKD","LU2023250330.USD","IE00B775H168.HKD","LU2324357040.USD","LU2168564149.EUR","LLYX","IXJ","LU2360106947.USD","LU0097036916.USD","LU0323591593.USD","LU0385154629.USD","IE00BJT1NW94.SGD","PPH","LU0353189763.USD","LU1868836591.USD","LU2023250504.SGD","IE00B7KXQ091.USD","LU2361045086.USD","LU0256863902.USD","SGXZ57979304.SGD","LU1629891620.HKD","IE00B4R5TH58.HKD","LU1868837136.USD","LU2265009873.SGD","LU2746668974.SGD","LU0354030438.USD","LU0133085943.USD","LU2491050071.SGD","BK4585","BK4516","AGNG","SGXZ99366536.SGD","LU1720051108.HKD","LU0471298694.HKD","LU1712237335.SGD","LU0094547139.USD","LU2168564065.EUR","LU0225283273.USD","LLY","MEDI","LU1814569148.SGD","LU0820562030.AUD","LU0238689110.USD","FTXH","IE0002141913.USD","NVOX","LU0345770308.USD","LU0061475181.USD","LU2168564222.USD","LU2462157665.USD","LU0122379950.USD","LU1804176565.USD","HRTS","IE00BKDWB100.SGD","IE00BFSS7M15.SGD","LU0823416689.USD","LU0882574055.USD","GB00BDT5M118.USD","LU2089284900.SGD","LU2236285917.USD","LU2271345857.HKD","IE00BJLML261.HKD","LU0289739699.SGD","LU1366192091.USD","LU1868836757.USD","IE00BK4W5M84.HKD","LU1093756325.SGD","THNR","LU0210536198.USD","BK4533","LU1035775433.USD","IE00BKVL7J92.USD","ELIS","LU0234572021.USD","LU0345770993.USD","LU0456855351.SGD","SG9999001176.USD","SG9999015986.USD","IE00BZ1G4Q59.USD","LU2746668461.USD","LU1069344957.HKD","RXL","IE00B1XK9C88.USD","JDOC","LU1551013342.USD","LU2264538146.SGD","LU0466842654.USD","LU1551013425.SGD","LU2491049909.HKD","SG9999014906.USD","LU0640476718.USD","LU2111349929.HKD","SG9999001176.SGD","NVOH","LU2108987350.USD","IE0009355771.USD","LU1917777945.USD","BK4599","LU0787776722.HKD","LU2471134796.USD","LU2552382215.SGD","SG9999018865.SGD","LU0256863811.USD","XLV","BK4588","LU2106854487.HKD","LU1232071149.USD","LU2023251221.USD","LU2237438978.USD","LU2237443549.SGD","LU2471134952.CNY","IE0004445239.USD","LU1974910355.USD","LU2552382058.USD","LU0683600562.USD","LU2491050154.USD","FHLC","LU0096364046.USD","LU0882574139.USD","LU0417517546.SGD","CURE","LU1127390331.HKD","LU1057294990.SGD","LU1989771016.USD","SG9999013999.USD","IE00B2B36J28.USD","LU0198837287.USD","LU2089984988.USD","BK4581","IE0001KFT4U8.USD","VHT","LU2461242641.AUD","LU0320765059.SGD","LU2211815571.USD","LU0158827781.USD","BK4534","LU2168563687.JPY","LU2361044865.SGD","LU0106261372.USD","BK4007","LU0964807845.USD","LU1623119135.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651248882","title":"Novo Nordisk’s New Diabetes Bet: What the UBT251 Trial Could Mean for NVO Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2651248882","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651248882?lang=en_us&edition=fundamental","pubTime":"2026-07-15 00:31","pubTimestamp":1784046673,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The Phase 2 study Efficacy and Safety of Once-weekly Subcutaneous UBT251 i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisks-new-diabetes-bet-what-the-ubt251-trial-could-mean-for-nvo-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisks-new-diabetes-bet-what-the-ubt251-trial-could-mean-for-nvo-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","NVOH","IE00BKVL7J92.USD","NVO","LU0154236417.USD","BK4532","IE00BZ1G4Q59.USD","OZEM","BK4585","NVOX","BK4588","PPH","BK4007","LU1093756168.USD","LU1093756325.SGD","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651514592","title":"Novo Nordisk Ramps Up Share Buybacks Under DKK 15 Billion Programme","url":"https://stock-news.laohu8.com/highlight/detail?id=2651514592","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651514592?lang=en_us&edition=fundamental","pubTime":"2026-07-14 01:18","pubTimestamp":1783963135,"startTime":"0","endTime":"0","summary":"Novo Nordisk ( ($NVO) ) has shared an announcement. Novo Nordisk A/S reported progress on its ongoing share repurchase programme, part of a broader...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-ramps-up-share-buybacks-under-dkk-15-billion-programme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-ramps-up-share-buybacks-under-dkk-15-billion-programme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OZEM","BK4585","BK4007","NVO","BK4532","THNR","PPH","LU1093756325.SGD","NVOH","IE00BKVL7J92.USD","LU0154236417.USD","BK4599","IE00BZ1G4Q59.USD","BK4588","LU1093756168.USD","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651433621","title":"Novo Nordisk A/S Stock Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2651433621","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651433621?lang=en_us&edition=fundamental","pubTime":"2026-07-14 00:02","pubTimestamp":1783958520,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S advanced 0.7% to DKK324.40 Monday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.2% to 2,704.89.This was the stock's second consecutive day of gains.The company closed DKK140.20 short of its 52-week high of DKK464.60, which the company achieved on July 28, 2025.Trading volume was 2,304,422, compared to the 50-day average trading volume of 5,455,322.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 13, 2026 12:02 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4585","NVOX","BK4007","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","NVOH","LU1093756325.SGD","PPH","THNR","BK4588","OZEM","BK4599","LU0154236417.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}